Showing results (271-280 of 302) with videos related to
Sort By:
Pageof 31
Neurology|August 22, 2022
Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer DiseaseOrnella V Billette, Gabriel Ziegler, Merita Aruci, et al.Journal of Alzheimer'S Disease : JAD|February 22, 2023
A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease ContinuumErsin Ersoezlue, Robert Perneczky, Maia Tato, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 26, 2024
Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyLara Blömeke, Fabian Rehn, Victoria Kraemer-Schulien, et al.Neurobiology of Aging|December 8, 2022
Lifelong experiences as a proxy of cognitive reserve moderate the association between connectivity and cognition in Alzheimer's diseaseErsin Ersoezlue, Boris-Stephan Rauchmann, Thomas Schneider-Axmann, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 28, 2023
APOE and immunity: Research highlightsCourtney M Kloske, Christopher J Barnum, Andre F Batista, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 19, 2020
Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patientsSofia Finsterwalder, Naomi Vlegels, Benno Gesierich, et al.EMBO Molecular Medicine|October 11, 2021
A microRNA signature that correlates with cognition and is a target against cognitive declineMd Rezaul Islam, Lalit Kaurani, Tea Berulava, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2024
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity ConferenceCourtney M Kloske, Simin Mahinrad, Christopher J Barnum, et al.Nature Genetics|July 7, 2014
Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasiaInes Gockel, Jessica Becker, Mira M Wouters, et al.Alzheimer'S Research & Therapy|January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE studyFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.Pageof 31